FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Teva Pharmaceuticals Vecuronium Bromide for Injection 10 mg Recall

Vecuronium Bromide for Injection 10 mg, 10mL vial, Rx only, Teva Pharmaceuticals USA, N…

Teva Pharmaceuticals USA · Parsippany, NJ

Risk level
Class II
Reported by FDA
Aug 25, 2021
Recall ID
D-0735-2021
Check your lot numberHow we source this data

Summary

Teva Pharmaceuticals recalled Vecuronium Bromide for Injection 10 mg starting Jul 29, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0735-2021 on Aug 25, 2021. Reason: Lack of Assurance of Sterility. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility

Product description

Vecuronium Bromide for Injection 10 mg, 10mL vial, Rx only, Teva Pharmaceuticals USA, North Wales, PA 19454, NDC 0703-2914-01

Lot numbers, UPCs & expiration codes

Lot #: 31325960B, exp. date12/2021; 31326111B, exp. date 01/2022; 31326875B, exp. date 03/2022; 31326915B, exp. date 03/2022; 31326916B, 31326917B, exp. date 04/2022; 31329079B, exp. date 04/2023; 31329085B, exp. date 05/2023

Where it was sold

Product was distributed Nationwide, including Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0735-2021
Classification
Class II
Status
Terminated
Recall initiated
Jul 29, 2021
FDA report date
Aug 25, 2021
Quantity
62,358 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Teva Pharmaceuticals USA

Original FDA data

Every field from FDA enforcement report D-0735-2021, exactly as published.

Show all FDA fields
City
Parsippany
State
NJ
Status
Terminated
Country
United States
Event ID
88442
Address
400 Interpace Pkwy
Code information
Lot #: 31325960B, exp. date12/2021; 31326111B, exp. date 01/2022; 31326875B, exp. date 03/2022; 31326915B, exp. date 03/2022; 31326916B, 31326917B, exp. date 04/2022; 31329079B, exp. date 04/2023; 31329085B, exp. date 05/2023
Postal code
07054-1120
Report date
Aug 25, 2021
Product type
Drugs
Recall number
D-0735-2021
Classification
Class II
Recalling firm
Teva Pharmaceuticals USA
Product quantity
62,358 vials
Termination date
Jun 4, 2024
Reason for recall
Lack of Assurance of Sterility
Voluntary / mandated
Voluntary: Firm initiated
Product description
Vecuronium Bromide for Injection 10 mg, 10mL vial, Rx only, Teva Pharmaceuticals USA, North Wales, PA 19454, NDC 0703-2914-01
Distribution pattern
Product was distributed Nationwide, including Puerto Rico.
Recall initiation date
Jul 29, 2021
Initial firm notification
Letter
Center classification date
Aug 16, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0735-2021, published Aug 25, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls